The Chemours Company Provides Update on Second Quarter 2025 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Chemours (CC) pre-announcement more 'positive than negative' - BMO Capital
June 18, 2025 9:21 AM EDTBMO Capital analyst John McNulty reiterated an Outperform rating and $17.00 price target on Chemours (NYSE: CC) after the company issued a negative Q2 pre-announcement, which has sent the stock down 1% in pre-open trading. The analyst said the pre-annocement has more positive than negatives... More
